Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer
This study has been terminated.
(Low accrual--unable to meet accrual goals)
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
First received: December 14, 2011
Last updated: February 10, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||February 2014|
|Primary Completion Date:||February 2014 (Final data collection date for primary outcome measure)|